BOSTON, June 16 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, will present in more than 20 sessions at the Drug Information Association (DIA) 44th Annual Meeting. The meeting will be held June 22 -- 26, 2008 at the Boston Convention and Exhibition Center in Boston, Massachusetts, home to PAREXEL's global headquarters office. PAREXEL experts will address key industry topics including global regulatory and drug development strategy, multinational clinical studies, and data-driven patient recruitment, as well as biosimilars, gene therapy regulations, genomics study methods, early-stage biotechnology product development, nanotechnology, and medical imaging biomarkers.
For more than 25 years clients have relied on PAREXEL to provide
in-depth expertise in integrated clinical development, medical
communications, and regulatory affairs, as well as advanced technologies
that help clients expedite time-to-market and peak-market penetration.
Attendees at the DIA Annual Meeting can visit PAREXEL experts at Booth #803
in the exhibit hall. Demonstrations of the Company's technologies,
including the market-leading Clinical Trial Management System IMPACT(R)
technology, will be provided by PAREXEL's technology subsidiary, Perceptive
PAREXEL experts will present or chair the following sessions:
Sunday, June 22
-- A Device Primer: IDEs, 510(k)s, PMAs, and Beyond -- Barry Sall,
Principal Consultant, PAREXEL Consulting (8:30 a.m. -- 12:00 p.m.)
Monday, June 23
-- Regulatory Strategy as a Key Component of the Global Multidisciplinary
Drug Development Strategy: Regulatory Intelligence
|SOURCE PAREXEL International Corporation|
Copyright©2008 PR Newswire.
All rights reserved